|
Volumn 37, Issue 3, 2002, Pages 387-392
|
C4A deficiency and nonresponse to hepatitis B vaccination
|
Author keywords
B cell; Major histocompatibility complex; Responder; Vaccine failure
|
Indexed keywords
COMPLEMENT COMPONENT C4;
HEPATITIS B VACCINE;
HLA ANTIGEN CLASS 2;
HLA DR ANTIGEN;
COMPLEMENT COMPONENT C4A;
HEPATITIS B ANTIBODY;
HLA-DRB1 ANTIGEN;
ADULT;
AGAR GEL ELECTROPHORESIS;
ALLOTYPE;
ANTIBODY PRODUCTION;
ARTICLE;
B LYMPHOCYTE;
COMPLEMENT ACTIVATION;
COMPLEMENT DEFICIENCY;
DRUG RESPONSE;
FEMALE;
GENE DELETION;
HEPATITIS B;
HUMAN;
MAJOR CLINICAL STUDY;
MAJOR HISTOCOMPATIBILITY COMPLEX;
MALE;
POLYACRYLAMIDE GEL ELECTROPHORESIS;
PRIORITY JOURNAL;
SOUTHERN BLOTTING;
TREATMENT FAILURE;
VACCINATION;
BLOOD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
EPIDEMIOLOGY;
GENETICS;
HAPLOTYPE;
IMMUNOLOGY;
MIDDLE AGED;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
STATISTICAL MODEL;
ADULT;
B-LYMPHOCYTES;
COMPLEMENT 4A;
FEMALE;
GENE DELETION;
HAPLOTYPES;
HEPATITIS B;
HEPATITIS B ANTIBODIES;
HEPATITIS B VACCINES;
HLA-DR ANTIGENS;
HUMAN;
LOGISTIC MODELS;
MALE;
MIDDLE AGE;
PROSPECTIVE STUDIES;
SEROEPIDEMIOLOGIC STUDIES;
SUPPORT, NON-U.S. GOV'T;
TREATMENT FAILURE;
COMPLEMENT C4A;
HUMANS;
MIDDLE AGED;
|
EID: 0036708289
PISSN: 01688278
EISSN: None
Source Type: Journal
DOI: 10.1016/S0168-8278(02)00205-2 Document Type: Article |
Times cited : (57)
|
References (25)
|